Scandinavian ChemoTech: Zapping Cancer - Redeye

Redeye initiates coverage of Scandinavian ChemoTech, a Swedish medtech company in early-stage commercialisation with its tumour-specific electroporation (TSE) treatment method for both humans and animal cancer patients. Scandinavian ChemoTech awaits case study data from superficial and deep-seated tumours, and we believe its technology has the potential to disrupt the cancer market.

Länk till analysen i sin helhet: https://www.redeye.se/research/889515/scandinavian-chemotech-zapping-cancer?utm_source=finwire&utm_medium=RSS